TrialCancer research communications2026

Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.

Enriqueta Felip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.